Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacogenetics and Pharmacogenomics: Overview01:29

Pharmacogenetics and Pharmacogenomics: Overview

Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
Growth versus Fixed Mindset01:24

Growth versus Fixed Mindset

Carol Dweck introduced the term mindset to describe individuals' beliefs about their intellectual and personal capabilities. These beliefs significantly influence psychological processes such as motivation, goal-setting, and perseverance, ultimately shaping academic and life outcomes. Individuals generally possess one of two mindsets- a fixed or a growth mindset—each promoting different responses to success, failure, and challenge.Fixed vs. Growth MindsetA fixed mindset assumes that one's...
Critical Thinking II01:25

Critical Thinking II

Critical thinking is a cognitive process with several attributes. The attributes of critical thinking include the following:
Interdisciplinary Care: The Health Care Team-I01:21

Interdisciplinary Care: The Health Care Team-I

An interdisciplinary team includes many healthcare professionals working together and utilizing their skills, knowledge, and expertise to provide holistic and quality patient care.
Physicians
The physician's primary responsibility is to diagnose illness and direct the medical or surgical treatment of the condition. The authority to admit patients to a healthcare agency or institution and practice care within that setting is granted to physicians by the healthcare agency or institution itself.
Interdisciplinary Care: The Health Care Team-II01:18

Interdisciplinary Care: The Health Care Team-II

An interdisciplinary team includes many healthcare professionals working together and utilizing their skills, knowledge, and expertise to provide holistic and quality patient care. Here are a few more healthcare professionals.
Physical Therapist
A physical therapist (PT) aims to restore function or prevent additional impairment in a patient following an injury or disease. Massage, heat, cold, water, sonar waves, exercises, and electrical stimulation are some treatments used by PTs to treat...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adipose tissue as a site of immune activation and dysfunction in individuals with obesity and asthma.

bioRxiv : the preprint server for biology·2026
Same author

Modest Contribution of Bradykinin to Blood Pressure Reduction by Sacubitril/Valsartan in Chronic Heart Failure.

Circulation. Heart failure·2026
Same author

Risk of Coronary Artery Disease Associated With Transitions in Metabolic Health in a Clinical Cohort of 69 272.

Journal of the American Heart Association·2025
Same author

RISING STARS: Effects of a GLP-1 receptor polymorphism on responses to liraglutide.

The Journal of endocrinology·2025
Same author

Regional and systemic adipose mass and peripheral conduit artery function.

Diabetes research and clinical practice·2025
Same author

Increased formation of angiotensin II from angiotensin I in individuals of African descent.

Journal of hypertension·2025
Same journal

THE GORDON WILSON MEMORIAL LECTURE.

Transactions of the American Clinical and Climatological Association·2025
Same journal

HEALTHY AGING: THE PROMISE, AND PERILS, OF GEROSCIENCE.

Transactions of the American Clinical and Climatological Association·2025
Same journal

TESTOSTERONE AND INSULIN RESISTANCE IN MEN: EVIDENCE FOR A COMPLEX BI-DIRECTIONAL RELATIONSHIP.

Transactions of the American Clinical and Climatological Association·2025
Same journal

REVISITING GLUCAGON ACTION IN DIABETES: IS IT ALL BAD?

Transactions of the American Clinical and Climatological Association·2025
Same journal

DECEASED MEMBERS 1884 THROUGH 2024.

Transactions of the American Clinical and Climatological Association·2025
Same journal

OFFICERS AND COUNCIL FALL 2025.

Transactions of the American Clinical and Climatological Association·2025
See all related articles

Related Experiment Video

Updated: May 9, 2026

Ole Isacson: Development of New Therapies for Parkinson's Disease
23:53

Ole Isacson: Development of New Therapies for Parkinson's Disease

Published on: April 29, 2007

Developing physician-scientists: a perspective

Nancy J Brown1

  • 1D-3100 Medical Center North, Vanderbilt University School of Medicine, Nashville, TN 37232-2358, USA. nancy.j.brown.@Vanderbilt.edu

Transactions of the American Clinical and Climatological Association
|July 23, 2013
PubMed
Summary

No abstract available in PubMed .

More Related Videos

Development of New Therapeutic Applications Using Microfluidics
08:56

Development of New Therapeutic Applications Using Microfluidics

Published on: October 1, 2007

Using Micro-Electro-Mechanical Systems (MEMS) to Develop Diagnostic Tools
16:05

Using Micro-Electro-Mechanical Systems (MEMS) to Develop Diagnostic Tools

Published on: October 1, 2007

Related Experiment Videos

Last Updated: May 9, 2026

Ole Isacson: Development of New Therapies for Parkinson's Disease
23:53

Ole Isacson: Development of New Therapies for Parkinson's Disease

Published on: April 29, 2007

Development of New Therapeutic Applications Using Microfluidics
08:56

Development of New Therapeutic Applications Using Microfluidics

Published on: October 1, 2007

Using Micro-Electro-Mechanical Systems (MEMS) to Develop Diagnostic Tools
16:05

Using Micro-Electro-Mechanical Systems (MEMS) to Develop Diagnostic Tools

Published on: October 1, 2007